What does GSK plc hold?

GSK plc's largest disclosed positions on the most recent Form 13F-HR filing on SEC EDGAR include CRSP, WVE, BNTX. Full top-holdings list, quarter-over-quarter position changes, and sector allocation breakdown are available at https://13fpro.ai/research/fund/1131399.

What is GSK plc's AUM?

GSK plc reported approximately $599.2M in 13F-reportable AUM as of 2026-03-31. This figure reflects long US-listed positions disclosed on Form 13F-HR and excludes non-13F-reportable holdings (cash, short positions, certain derivatives, and non-US securities).

Where does 13F Pro source GSK plc's holdings?

All GSK plc holdings data comes directly from SEC EDGAR Form 13F-HR filings under CIK 1131399. Data refreshes automatically each quarter as new 13F filings are submitted (typically within 45 days of quarter-end). 13F Pro applies no third-party rewrites or estimates.

How often is GSK plc's 13F data updated on 13F Pro?

GSK plc's holdings update on 13F Pro within hours of each new Form 13F-HR filing on SEC EDGAR. Quarterly position changes, accumulation/distribution flags, and sector allocation are recalculated on each refresh.

GSK plc

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1131399

Institutional-grade research for retail investors

13F Reported Value

ⓘ

$599.2M

Holdings

Latest Filing

2026-03-31

Filing Quarter

Q1 2026

Portfolio Overview

GSK plc disclosed 13 positions worth $599.2M in its Form 13F-HR for Q1 2026, led by $CRSP (CRISPR Therapeutics AG) at 25.6% of the equity portfolio, followed by $WVE and $BNTX. During the quarter the fund opened 0 new positions and exited 2 and a full exit from $SENS. The portfolio is most concentrated in Healthcare (100.0% of disclosed assets). All figures are sourced directly from GSK plc’s Form 13F-HR filing with the SEC under CIK 1131399.

Sector Allocation

Healthcare

AUM History

Top Equity Holdings by Value

Quarterly Activity — Q1 2026

Click any card to unlock

Top Holdings

AI Quality Scored

CRISPR Therapeutics AG
$CRSP
4.5#2,853
Quality
$153.2M3,220,627 sh
Wave Life Sciences Ltd.
$WVE
—
Quality
$132.3M18,245,691 sh
BioNTech SE
$BNTX
—
Quality
$79.1M889,824 sh
Vir Biotechnology, Inc.
$VIR
5.6
Quality
$76.6M8,550,954 sh
IDEAYA Biosciences, Inc.
$IDYA
10.5
Quality
$44.4M1,333,333 sh
Lyell Immunopharma, Inc.
$LYEL
3.6
Quality
$30.3M1,512,659 sh
CYTOKINETICS INC
$CYTK
28.0
Quality
$22.4M340,434 sh
Spero Therapeutics, Inc.
$SPRO
19.5
Quality
$21.5M9,190,606 sh
Fulcrum Therapeutics, Inc.
$FULC
—
Quality
$13.7M1,785,714 sh
CVRx, Inc.
$CVRX
24.3
Quality
$9.5M1,007,583 sh

Company	Quality	Value	Shares
CRISPR Therapeutics AG$CRSP	4.5#2,853	$153.2M	3,220,627
Wave Life Sciences Ltd.$WVE	—	$132.3M	18,245,691
BioNTech SE$BNTX	—	$79.1M	889,824
Vir Biotechnology, Inc.$VIR	5.6	$76.6M	8,550,954
IDEAYA Biosciences, Inc.$IDYA	10.5	$44.4M	1,333,333
Lyell Immunopharma, Inc.$LYEL	3.6	$30.3M	1,512,659
CYTOKINETICS INC$CYTK	28.0	$22.4M	340,434
Spero Therapeutics, Inc.$SPRO	19.5	$21.5M	9,190,606
Fulcrum Therapeutics, Inc.$FULC	—	$13.7M	1,785,714
CVRx, Inc.$CVRX	24.3	$9.5M	1,007,583

Unlock AI quality scores for every holding

32-signal composite ranking on each of GSK plc's 13 positions.

Showing top 10 of 13 holdings.

Sector Allocation

Healthcare

$599.2M

Full Holdings — GSK plc (Q1 2026)

All 13 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

#	Ticker	Company	Value	Weight	QoQ	Quality
1	$CRSP	CRISPR Therapeutics AG	$153.2M	25.6%	+0%	4.5
2	$WVE	Wave Life Sciences Ltd.	$132.3M	22.1%	+0%	—
3	$BNTX	BioNTech SE	$79.1M	13.2%	+0%	—
4	$VIR	Vir Biotechnology, Inc.	$76.6M	12.8%	+0%	5.6
5	$IDYA	IDEAYA Biosciences, Inc.	$44.4M	7.4%	+0%	10.5
6	$LYEL	Lyell Immunopharma, Inc.	$30.3M	5.1%	+0%	3.6
7	$CYTK	CYTOKINETICS INC	$22.4M	3.7%	+0%	28
8	$SPRO	Spero Therapeutics, Inc.	$21.5M	3.6%	+0%	19.5
9	$FULC	Fulcrum Therapeutics, Inc.	$13.7M	2.3%	+0%	—
10	$CVRX	CVRx, Inc.	$9.5M	1.6%	+0%	24.3
11	$BCYC	BICYCLE THERAPEUTICS PLC	$7.1M	1.2%	+0%	—
12	$NKTX	Nkarta, Inc.	$6.6M	1.1%	+0%	—
13	$RGNX	REGENXBIO Inc.	$2.3M	0.4%	+0%	26.9

Exited Positions (2)

$SENS Senseonics Holdings, Inc.

$HBIO HARVARD BIOSCIENCE INC

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire Hathaway Bridgewater Associates Citadel Advisors Renaissance Technologies Two Sigma Investments DE Shaw & Co Millennium Management AQR Capital Management Point72 Asset Management Tiger Global Management Vanguard Group BlackRock

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for GSK plc including:

Full 13F portfolio with all holdings

Quarter-over-quarter position changes

Accumulation & distribution patterns

Sector allocation breakdown

Historical portfolio evolution

New positions & complete exits

Concentration analysis

Peer comparison with similar funds

AI-powered portfolio insights

Track GSK plc's Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for GSK plc and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: GSK plc

13F Pro is an AI hedge fund tracker and stock research platform. For GSK plc (SEC CIK: 1131399), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in GSK plc's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.